Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 144.23B | 160.34B | 169.31B | 206.18B | 190.67B |
Gross Profit | 39.36B | 42.36B | 42.97B | 42.57B | 38.60B |
EBITDA | 18.73B | 26.02B | 25.79B | -26.14B | 16.91B |
Net Income | 5.68B | 12.48B | 42.49B | -39.84B | 1.23B |
Balance Sheet | |||||
Total Assets | 204.83B | 214.40B | 221.09B | 290.70B | 284.91B |
Cash, Cash Equivalents and Short-Term Investments | 25.48B | 21.00B | 17.84B | 28.22B | 27.98B |
Total Debt | 42.32B | 53.01B | 65.09B | 44.85B | 62.70B |
Total Liabilities | 83.77B | 94.36B | 113.23B | 160.63B | 115.83B |
Stockholders Equity | 116.73B | 114.92B | 103.48B | 126.08B | 165.57B |
Cash Flow | |||||
Free Cash Flow | 17.99B | 15.14B | 10.24B | 6.57B | 10.44B |
Operating Cash Flow | 23.59B | 22.24B | 16.60B | 14.87B | 17.92B |
Investing Cash Flow | -4.24B | -3.34B | 19.96B | -1.84B | -3.74B |
Financing Cash Flow | -17.57B | -15.97B | -47.04B | -12.74B | -13.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ¥180.86B | 11.30 | 5.69% | 3.08% | 2.67% | -11.84% | |
58 Neutral | ¥83.26B | 23.79 | 5.06% | -8.57% | -72.36% | ||
― | $886.18M | 13.54 | 5.18% | 2.94% | ― | ― | |
― | $3.02B | 9.06 | 8.42% | 2.12% | ― | ― | |
76 Outperform | ¥146.64B | 10.71 | 2.55% | 1.36% | 12.13% | ||
73 Outperform | ¥25.13B | 14.48 | 5.31% | -3.07% | -44.51% | ||
69 Neutral | ¥23.08B | 8.12 | 3.77% | 5.63% | 6.00% |
Central Glass Co., Ltd. announced the sale of its consolidated subsidiary, Apollo Scientific Ltd., to Shanghai Titan Scientific Co., Ltd. due to ASL’s recent underperformance and the company’s strategic shift away from the reagent business. This decision aligns with Central Glass’s strategy to enhance corporate value by focusing on more profitable sectors, although it will result in an extraordinary loss in the upcoming fiscal year.
Central Glass Co., Ltd. announced corrections to a previous notice regarding its transition to a company with an Audit and Supervisory Committee and amendments to its Articles of Incorporation. These corrections involve changes in the company’s organizational structure and the scope of its business activities, which may impact its governance and operational focus.
Central Glass Co., Ltd. has announced a decision to pay dividends from retained earnings, with a record date of March 31, 2025. The dividend per share is set at 85 yen, reflecting the company’s strategy to maintain stable dividends aligned with business performance and long-term growth plans. This decision is part of their medium-term management plan, which aims for a total return ratio of 30% or more and a dividends on equity ratio of 3.6%.
Central Glass Co., Ltd. has announced a Medium-Term Management Plan for FY2025-FY2030, aiming to achieve its VISION 2030 targets of 20 billion yen in operating profit and a minimum 10% ROE. The plan includes a phased approach to strengthen growth foundations and drive substantial growth, with a focus on optimizing the business portfolio, enhancing capital efficiency, and integrating ESG management. Additionally, the company will expand its disclosure segments to improve transparency, reflecting a strategic shift towards diversified business areas.
Central Glass Co., Ltd. reported a decline in its financial performance for the fiscal year ended March 31, 2025, with net sales dropping by 10% and a significant decrease in profit attributable to owners of the parent by 54.5%. Despite the challenging year, the company increased its annual dividend per share, indicating a commitment to returning value to shareholders. The financial forecast for the upcoming year suggests a slight recovery in net sales but continued pressure on profits, reflecting ongoing challenges in the market.